<DOC>
	<DOCNO>NCT00879788</DOCNO>
	<brief_summary>The study conduct open label , balance , randomize , two-treatment , two-period , two-sequence , single-dose , crossover bioavailability study compare ramipril 10 mg capsule Ohm Laboratories Inc. , AltaceÂ® capsule 10 mg ( contain ramipril 10 mg ) manufacture King Pharmaceuticals Inc , Bristol Distributed Monarch Pharmaceuticals Inc , Bristol healthy , adult , male , human subject feed condition .</brief_summary>
	<brief_title>Bioequivalence Study Ramipril 10 mg Capsules Under Fed Conditions</brief_title>
	<detailed_description>A single oral dose ramipril 10 mg capsule administer 240 mL drinking water ambient temperature 30 minute start high-fat high-caloric breakfast supervision train study personnel . A total thirty-two ( 32 ) subject randomize receive single oral dose test ( T ) reference ( R ) formulation ramipril 10 mg capsule . One subject ( subject No . 18 ) withdrawn one dropped ( subject No . 10 ) study period I . One subject ( subject No . 20 ) drop two subject withdraw ( subject No . 27 , 29 ) study period II . A total twenty-seven ( 27 ) subject complete period study .</detailed_description>
	<mesh_term>Ramipril</mesh_term>
	<criteria>1 . Were age range 1845 year . 2 . Were neither overweight underweight correspond height per Life Insurance Corporation India height/weight chart nonmedical case . 3 . Had voluntarily give write informed consent participate study . 4 . Were normal health determine medical history physical examination subject perform within 21 day prior commencement study . 5 . Had nonvegetarian diet habit . 1 . Hypersensitivity , allergy ramipril relate group drug . 2 . History anaphylaxis/anaphylactoid reaction . 3 . History fever week precede study . 4 . History seizure sleep disorder . 5 . History chronic cough , bronchial asthma . 6 . Subject sit systolic blood pressure le 90 mmHg &gt; 140 mmHg diastolic blood pressure le 60 mmHg &gt; 90 mmHg predose . 7 . History frequent syncopal attack , frequent palpitation . 8 . History angina , myocardial infarction angioedema . 9 . History severe diarrhea vomit week precede study . 10 . History dry cough . 11 . History congestive heart failure . 12 . Any evidence organ dysfunction clinically significant deviation normal , physical clinical determination . 13 . Presence disease marker HIV 1 2 , Hepatitis B C viruses syphilis infection . 14 . Presence value significantly different normal reference range and/or judge clinically significant hemoglobin , total white blood cell count , differential WBC count platelet count . 15 . Positive urinary screen test drug abuse ( opiates cannabinoids ) . 16 . Presence value significantly different normal reference range and/or judge clinically significant serum creatinine , blood urea nitrogen , serum aspartate aminotransferase ( AST ) , serum alanine aminotransferase ( ALT ) , serum alkaline phosphatase , serum bilirubin , plasma glucose serum cholesterol . 17 . Clinically abnormal chemical microscopic examination urine define presence RBC , WBC ( &gt; 4/HPF ) , glucose ( positive ) protein ( positive ) . 18 . Clinically abnormal ECG Chest Xray . 19 . History serious gastrointestinal , hepatic , renal , cardiovascular , pulmonary , neurological hematological disease , diabetes glaucoma . 20 . History psychiatric illness , might impair ability provide write informed consent . 21 . Regular smoker smoke 10 cigarette daily difficulty abstain smoke duration study period . 22 . History drug dependence excessive alcohol intake habitual basis 2 unit alcoholic beverage per day ( 1 unit equivalent half pint beer 1 glass wine 1 measure spirit ) difficulty abstain duration study period . 23 . Use enzyme modifying drug within 30 day prior Day 1 study . 24 . Participation clinical trial within 12 week precede Day 1 study . 25 . Subjects , completion study , donate and/or lose 350 mL blood past 3 month .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Ramipril feed condition</keyword>
</DOC>